Physician profile
Erik Beckmann
NPI 1801310065
$6,395.12
in general payments reported to CMS, 2019-2025
7 companies · $4,025 in 2025
The $4,025 reported for 2025 was more than what 79% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.53 · 2023: $2,019 · 2024: $327 · 2025: $4,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,266 · Food and Beverage: $1,830 · Consulting Fee: $1,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,265.56 |
| Food and Beverage | $1,830.03 |
| Consulting Fee | $1,275.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,070.93 | 2023-2025 | Mitris Resilia Mitral Valve, Konect Resilia, Carpentier-Edwards Physio II Annuloplasty Ring |
| Medtronic, INC. | $1,522.36 | 2023-2024 | Cardioblate Cryoflex, Penditure, Invos |
| Artivion, INC. | $1,236.89 | 2023-2025 | Amds-Ascyrus Medical, Bioglue Surgical Adhesive, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Atricure, INC. | $370.58 | 2022-2024 | |
| Abiomed | $111.34 | 2024 | Impella |
| Octapharma USA, INC. | $65.54 | 2025 | Fibryga |
| Zimmer Biomet Holdings, INC. | $17.48 | 2025 | Sternalock |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Beckmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.